Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Acute Coronary Syndrome
Jiawei Song,
Yanping Liu,
Yani Xu
et al.
Abstract:The evidence for sodium-glucose cotransporter 2 inhibitors
(SGLT2i)
in the treatment of type 2 diabetes or chronic heart failure was sufficient
but lacking in acute coronary syndrome (ACS). Our aim was to investigate
the effects of SGLT2i on cardiovascular outcomes in ACS patients.
Studies of SGLT2i selection in ACS patients were searched and pooled.
Outcomes included all-cause death, adverse cardiovascular events,
cardiac remodeling as measured by the left ventricular end-diastolic
dimension (LVEDD) and left … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.